Human rabies therapy: Lessons learned from experimental studies in mouse models

Developments in Biologicals

Volumn 131, Issue , 2008, Pages 377-385

  Jackson, Alan C ^a,b   Scott, C A ^c,d   Owen, J ^c   Weli, S C ^c   Rossiter, J P ^c,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b University of Man   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

Author keywords

Human; Ketamine; Minocycline; Rabies therapy

Indexed keywords

KETAMINE; MINOCYCLINE;

ANIMAL; APOPTOSIS; CONFERENCE PAPER; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; FEMALE; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; MOUSE; NERVE CELL; PATHOGENICITY; RABIES; RABIES VIRUS; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; KETAMINE; MICE; MICE, INBRED ICR; MINOCYCLINE; NEURONS; RABIES; RABIES VIRUS; TREATMENT OUTCOME;

EID: 44649143187     PISSN: 14246074     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (17)

1. Jackson AC, Warrell MJ, Rupprecht CE, Ertl HCJ, Dietzschold B, O'Reilly M, Leach RP, Fu ZF, Wunner WH, Bleck TP, Wilde H: Management of rabies in humans. Clin Infect Dis 2003;36:60-63.
2. Lockhart BP, Tsiang H, Ceccaldi PE, Guillemer S: Ketamine-mediated inhibition of rabies virus infection in vitro and in rat brain. Antivir Chem Chemother 1991;2:9-15.
3. Lockhart BP, Tordo N, Tsiang H: Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. Antimicrob Agents Chemother 1992;36:1750-1755.
4. Willoughby RE Jr., Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, Chusid MJ, Rupprecht CE: Survival after treatment of rabies with induction of coma. N Engl J Med 2005;352:2508-2514.
5. Jackson AC: Rabies: new insights into pathogenesis and treatment. Curr Opin Neurol 2006;19:267-270.
6. Hemachudha T, Sunsaneewitayakul B, Desudchit T, Suankratay C, Sittipunt C, Wacharapluesadee S, Khawplod P, Wilde H, Jackson AC: Failure of therapeutic coma and ketamine for therapy of human rabies. J Neurovirol 2006;12:407-409.
7. Christenson JC, Holm BM, Lechlitner S, Howell JF, Wenger M, Roy-Burman A, Hsieh CJ, LaBar L, Petru A, Davis S, Simons N, Apolinario P, Furst K, Benjamin B, Christie LJ, Schnurr D, Glaser CA, Rosenberg J, Sun B, Willoughby RE, Rupprecht CE: Human rabies-Indiana and California, 2006. MMWR Morb Mortal Wkly Rep 2007;56:361-365.
8. Schmiedel S, Panning M, Lohse A, Kreymann KG, Gerloff C, Burchard G, Drosten C: Case report on fatal human rabies infection in Hamburg, Germany, March 2007. Eurosurveillance 2007;12:E070531.5.
9. Yong VW, Wells J, Giuliani F, Casha S, Power C, Metz LM: The promise of minocycline in neurology. Lancet Neurol 2004;3:744-751.
10. Darman J, Backovic S, Dike S, Maragakis NJ, Krishnan C, Rothstein JD, Irani DN, Kerr DA: Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity. J Neurosci 2004;24:7566-7575.
11. Richardson-Burns SM, Tyler KL: Minocycline delays disease onset and mortality in reovirus encephalitis. Exp Neurol 2005;192:331-339.
12. Zink MC, Uhrlaub J, DeWitt J, Voelker T, Bullock B, Mankowski J, Tarwater P, Clements J, Barber S: Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 2005;293:2003-2011.
13. Jackson AC, Scott CA, Owen J, Weli SC, Rossiter JP: Minocycline therapy aggravates rabies in an experimental mouse model. J Virol 2007;81:6248-6253.
14. Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F: Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci 2004;19:3266-3276.
15. Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S, Shin DH, Browne SE, Shimizu Y, Job TH, Beal MF, Albers DS: Minocycline enhances MPTP toxicity to dopaminergic neurons. J Neurosci Res 2003;74:278-285.
16. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J: A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 1999;96:13496-13500.
17. Tsuji M, Wilson MA, Lange MS, Johnston MV: Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 2004;189:58-65.